Get startedLog in
    Picture of Apellis Pharmaceuticals logo

    APLS — Apellis Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Apellis Pharmaceuticals Q2 Basic EPS USD -0.3

    Picture of Apellis Pharmaceuticals logoApellis Pharmaceuticals
    01/08/2024 12:05
    Aug 01 (Reuters) - Apellis Pharmaceuticals Q2 product revenue USD 179.136
million.
* Q2 operating income USD -29.443 million
* Q2 operating expenses USD 229.128 million
* Q2 net income USD -37.657 million

    Recent news on Apellis Pharmaceuticals

    See all news